ENCell Co., Ltd. (KOSDAQ:456070)
16,750
+50 (0.30%)
Feb 19, 2026, 12:20 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 183.11 billion as of February 18, 2026. Its market cap has decreased by -11.92% in one year.
Market Cap
183.11B
Enterprise Value
166.07B
Revenue
5.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,750.00
Market Cap Chart
Since August 23, 2024, ENCell's market cap has increased from 160.82B to 183.11B, an increase of 13.86%. That is a compound annual growth rate of 9.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 183.11B | -7.76% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioneer | 332.44B |
| Helixmith | 310.82B |
| EASY BIO,Inc. | 250.10B |
| HLB Therapeutics | 240.96B |
| Genexine | 201.02B |
| MedPacto | 200.85B |
| Macrogen | 195.80B |
| GeneOne Life Science | 140.58B |